🇺🇸 FDA
Patent

US 8716017

Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells

granted A61KA61K35/30A61P

Quick answer

US patent 8716017 (Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells) held by San Diego Regenerative Medicine Institute expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
San Diego Regenerative Medicine Institute
Grant date
Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K35/30, A61P, A61P25/00, A61P25/16